Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phosphorus Metabolism Disorders”

281 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 281 results

Not applicableStudy completedNCT05897502
What this trial is testing

Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis

Who this might be right for
End-Stage Kidney DiseaseHyperphosphatemia
Liu, Liu-Yin 43
Not applicableUnknownNCT06054139
What this trial is testing

Risk Factors for Refeeding Syndrome in the Surgical Intensive Care Unit

Who this might be right for
Refeeding Syndrome
Samsun University 60
Not applicableActive Not RecruitingNCT04946409
What this trial is testing

Burden of Disease and Functional Impairment in XLH

Who this might be right for
X Linked Hypophosphatemia
Wuerzburg University Hospital 60
Early research (Phase 1)UnknownNCT00473187
What this trial is testing

Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets

Who this might be right for
Hypophosphatemic RicketsGrowth DisordersSomatropin Therapy
University of Rostock
Not applicableStudy completedNCT00967993
What this trial is testing

Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Who this might be right for
HyperphosphatemiaEnd-stage Renal DiseaseRenal Failure Chronic Requiring Hemodialysis
Keryx Biopharmaceuticals 22
Post-approval studies (Phase 4)Study completedNCT03079869
What this trial is testing

Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients

Who this might be right for
Hyperphosphatemia
Kaiser Permanente 55
Not applicableStudy completedNCT03529058
What this trial is testing

Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU

Who this might be right for
HypophosphatemiaInfection
University Hospital, Brest 193
Not applicableStudy completedNCT04579315
What this trial is testing

Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease(CKD)HyperphosphatemiaBlood Pressure
Bo Feldt-Rasmussen 60
Post-approval studies (Phase 4)Study completedNCT02209636
What this trial is testing

Phosphate Lowering in CKD Trial

Who this might be right for
Chronic Kidney DiseaseCardiovascular Disease
VA Office of Research and Development 66
Post-approval studies (Phase 4)Study completedNCT00211939
What this trial is testing

CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

Who this might be right for
CalcinosisArteriosclerosisHyperparathyroidism, Secondary
Nabi Biopharmaceuticals 203
Large-scale testing (Phase 3)Study completedNCT03920072
What this trial is testing

Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd 35
Large-scale testing (Phase 3)Study completedNCT04771780
What this trial is testing

Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Who this might be right for
Hyperphosphatemia
Kyowa Kirin Co., Ltd. 213
Testing effectiveness (Phase 2)Looking for participantsNCT06525636
What this trial is testing

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT04549597
What this trial is testing

Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia

Who this might be right for
Chronic Kidney Disease Requiring Chronic DialysisHyperphosphatemia
Ardelyx 333
Not applicableStudy completedNCT01857024
What this trial is testing

Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia

Who this might be right for
HyperphosphataemiaChronic Kidney Disease
Genzyme, a Sanofi Company 210
Not applicableUnknownNCT01057186
What this trial is testing

Hypophosphatemic Rickets in Norway

Who this might be right for
Hypophosphatemia, FamilialRicketsHyperphosphatemia
Haukeland University Hospital 80
Large-scale testing (Phase 3)Ended earlyNCT00833768
What this trial is testing

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis

Who this might be right for
Chronic Kidney DiseaseHyperphosphatemia
Genzyme, a Sanofi Company 5
Not applicableWithdrawnNCT00844740
What this trial is testing

Calcimimetics in Hypophosphatemic Rickets

Who this might be right for
Familial Hypophosphatemic Rickets
Children's Mercy Hospital Kansas City
Large-scale testing (Phase 3)Study completedNCT00268957
What this trial is testing

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

Who this might be right for
Kidney DiseasesChronic Renal InsufficiencyEnd-Stage Renal Disease
Genzyme, a Sanofi Company 217
Testing effectiveness (Phase 2)Study completedNCT00767637
What this trial is testing

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Who this might be right for
HyperphosphatemiaDialysis
Bayer 14
Load More Results